FDA approves Shire’s Motegrity™ (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation (CIC) Guest UserJanuary 8, 2019 Facebook0 Twitter LinkedIn0 0 Likes